Epidrugs in cancer : epigenetic profiling to improve treamtent for T-cell lymphoblastic leukemia and lymphoma
(2023)
- Author
- Lien Provez
- Promoter
- Pieter Van Vlierberghe (UGent) , Steven Goossens (UGent) and Maarten Dhaenens (UGent)
- Organization
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only (changes to open access on 2028-08-29)
- |
- |
- 21.67 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01H956EKDFG6696CFSGK0832BK
- MLA
- Provez, Lien. Epidrugs in Cancer : Epigenetic Profiling to Improve Treamtent for T-Cell Lymphoblastic Leukemia and Lymphoma. Ghent University. Faculty of Medicine and Health Sciences, 2023.
- APA
- Provez, L. (2023). Epidrugs in cancer : epigenetic profiling to improve treamtent for T-cell lymphoblastic leukemia and lymphoma. Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium.
- Chicago author-date
- Provez, Lien. 2023. “Epidrugs in Cancer : Epigenetic Profiling to Improve Treamtent for T-Cell Lymphoblastic Leukemia and Lymphoma.” Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
- Chicago author-date (all authors)
- Provez, Lien. 2023. “Epidrugs in Cancer : Epigenetic Profiling to Improve Treamtent for T-Cell Lymphoblastic Leukemia and Lymphoma.” Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
- Vancouver
- 1.Provez L. Epidrugs in cancer : epigenetic profiling to improve treamtent for T-cell lymphoblastic leukemia and lymphoma. [Ghent, Belgium]: Ghent University. Faculty of Medicine and Health Sciences; 2023.
- IEEE
- [1]L. Provez, “Epidrugs in cancer : epigenetic profiling to improve treamtent for T-cell lymphoblastic leukemia and lymphoma,” Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium, 2023.
@phdthesis{01H956EKDFG6696CFSGK0832BK,
author = {{Provez, Lien}},
language = {{eng}},
pages = {{XXVIII, 278}},
publisher = {{Ghent University. Faculty of Medicine and Health Sciences}},
school = {{Ghent University}},
title = {{Epidrugs in cancer : epigenetic profiling to improve treamtent for T-cell lymphoblastic leukemia and lymphoma}},
year = {{2023}},
}